Kyle Hornyak

Most Recent Articles by Kyle Hornyak

The Top 60: Cambridge BioMarketing

Boston shop adds big wins in the quest to break the $10 million mark in 2008

The Top 60: Area 23

Draftfcb's newest agency can already tout its impressive list of new clients

Medical meetings: Is Live CME Still Effective?

Traditional lecture-based CME will always have its place, but experts agree that alternative media is necessary for retention.

Email Newsletters


What does going "beyond the pill" actually mean? At MM&M's recent inaugural spring conference, audience members heard from real-world companies that are managing the organizational, technological, and promotional challenges inherent in this transition, such as partnering with health neophytes, harnessing technologies that allow deeper engagement with patients, and adopting a new commercial mindset to serve, not sell. Download here.


A wave of more effective anti-cancer drugs has set the oncology world on fire with enthusiasm. While many hail this as a new era, an equally vocal faction questions the money spent for the value gained. This medical and commercial trend report for marketers of anti-cancer modalities touches on many of the latest shifts that have expedited product launches and otherwise impacted promotion and reimbursement of these drugs. Click here.